Works from 2024
A Refractory Case of Catastrophic Antiphospholipid Syndrome (CAPS), Shanti Timilsina MD, Matthew Mahoney MD, Kidus Kebede MD, Abhay K. Jella MD, Salman Waheeduddin MD, and Joaquin Solis MD (Abstract)
Primary Gastric Squamous Cell Carcinoma Treated with CROSS Regimen, Josh Bahr, Rebecca Kirschner MD, and Wesley Papenfuss MD (Abstract)
PACE: A randomized phase II study of fulvestrant, palbociclib, and avelumab after progression on cyclin-dependent kinase 4/6 inhibitor and aromatase inhibitor for hormone receptor-positive/human epidermal growth factor receptor-negative metastatic breast cancer, Erica L. Mayer, Yue Ren, Nikhil Wagle, et al. (Article)
EROS: Engendering Reproductive Health within Oncologic Survivorship—ECOG-ACRIN E1Q11 paradoxical provision of reproductive health, Ashlesha Patel, Ju-Whei Lee, Rubina Qamar, et al. (Abstract)
If you build it, they will come: Success of the EROS (Engendering Reproductive Health Within Oncologic Survivorship)—ECOG-ACRIN E1Q11 in recruitment of minority patients, Ashlesha Patel, Ju-Whei Lee, Rubina Qamar, et al. (Abstract)
Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status, Shahzaad Khadeem Jahangier and Rubina Qamar (Abstract)
A Refractory Case of Catastrophic Antiphospholipid Syndrome (CAPS), Shanti Timilsina MD, Matthew Mahoney MD, Kidus Kebede MD, Abhay K. Jella MD, Salman Waheeduddin MD, and Joaquin Solis MD (Poster)
Primary Gastric Squamous Cell Carcinoma Treated with CROSS Regimen, Josh Bahr, Rebecca Kirschner MD, and Wesley Papenfuss MD (Poster)
Comparison of intermittent intravenous tacrolimus to continuous tacrolimus in adult allogeneic stem cell transplant recipients, Michael Williams, Zartash Gul, Justin Graff, et al. (Article)
Abstract PO4-09-11: Predictors of cardiotoxicity in early breast cancer patients treated with Doxorubicin and/or Trastuzumab: Implications of race/ethnicity and insurance status, Shahzaad Jahangier, Rubina Qamar, Vinay Thohan, et al. (Abstract)
Abstract PO5-15-01: Prospective biomarker assessment of cardiotoxicity among ethnically diverse women with early breast cancer, Shahzaad Jahangier, Rubina Qamar, Maharaj Singh, et al. (Abstract)
Noninferiority of hypofractionated vs conventional postprostatectomy radiotherapy for genitourinary and gastrointestinal symptoms: The NRG-GU003 phase 3 randomized clinical trial, Mark K. Buyyounouski, Stephanie L. Pugh, Ronald C. Chen, et al. (Article)
Abstract 3707: Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- metastatic breast cancer: Results from the PACE phase II study, Mara Serena Serafini, Carolina Reduzzi, Rubina Qamar, et al. (Abstract)
Use of type 1 interferon-alpha 2a for relapse prevention in allogeneic stem cell transplant, Michael Williams, Brittany Mejaki, Justin Graff, et al. (Abstract)
Breast cancer in the community, James Weese (Book Chapter)
Breast cancer: Multidisciplinary pathways for cancer care in the community, James Weese (Book)
Contemporary surgical approaches to breast cancer, Ashley Marumoto, Armando E. Guiliano, Ameer Gomberawalla, et al. (Book Chapter)
Expectations for the future, Amy Bock and James L. Weese (Book Chapter)
Multidisciplinary team approach to the management of breast cancer, Aaron H. Chevinsky and Joseph John Weber (Book Chapter)
Outcomes and quality indicators, Joseph John Weber, Aaron H. Chevinsky, and Carol Huibregtse (Book Chapter)
Radiation therapy, Kenneth T. Bastin, Ellen L. Ziaja, Greg Kauffmann, et al. (Book Chapter)
Systemic therapy for breast cancer, Sigrun Hallmeyer, Rubina Qamar, and Corey J. Shamah (Book Chapter)
Initial findings from the DREAM-GI national database: Assessing the efficacy and safety of neoadjuvant immunotherapy (NIT) in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) gastrointestinal (GI) cancer, Sakti Chakrabarti, J. Eva Selfridge, Antony Ruggeri, et al. (Abstract)
Works from 2023
Reducing Discharge Opioid Prescription After Breast Conservation Surgery: A Systemwide Multihospital Quality Improvement Initiative, Joseph J. Weber, Jodi Brehm, Julie Kepple, Meredith Witten, Nicole M. Zaremba, Carol Huibregtse, Anne Weers, and James L. Weese (Abstract)
Sclerosing Angiomatoid Nodular Transformation Appearing as Metastatic Disease in a Patient With Multiple Endocrine Neoplasia Type I, Rebecca C. Kirschner, Zane G. Staubach, and Wesley A. Papenfuss (Abstract)
Survival of Women Diagnosed With Stage IV Breast Cancer and Brain Metastases by Molecular Subtype, Maharaj Singh, Meredith Witten, and Richard Rovin (Abstract)
Brief report on use of pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis, Monika A. Izano, Connor Sweetnam, Chenan Zhang, et al. (Article)
Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study, Lorenzo Gerratana, Yue Ren, Rubina Qamar, et al. (Abstract)
Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system, Noor Naffakh, Michael Williams, Priyam Patel, et al. (Abstract)
Pulmonary open, robotic and thoracoscopic lobectomy (PORTaL) study: Survival analysis of 6,646 cases, Michael S. Kent, Matthew G. Hartwig, Eric Vallières, et al. (Article)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Sclerosing Angiomatoid Nodular Transformation (SANT) Appearing as Metastatic Disease in a Patient With Multiple Endocrine Neoplasia Type I, Rebecca C. Kirschner, Zane G. Staubach, and Wesley A. Papenfuss (Poster)
Transhiatal Esophagectomy With Transcervical Endoscopic Esophageal Mobilization is a Minimally Invasive Technique for Esophagectomy With Favorable Oncologic and Perioperative Outcomes, Isaac R. Kriley, Noah Rozich, Rebecca Kirschner, James Adefisoye, Amanda Mueller, Elizabeth Colwell, Geoffrey Bellini, David Demos, William Tisol, and Wesley Papenfuss (Poster)
Impact of donation after circulatory death allografts on outcomes following simultaneous liver-kidney transplant: A single-center experience and review of the literature, Shiva Kumar, Rachel Pedersen, and Ajay Sahajpal (Article)
E372: Transhiatal esophagectomy with transcervical endoscopic esophageal mobilization is a minimally invasive approach with favorable oncologic and perioperative outcomes, Isaac R. Kriley, Noah Rozich, Rebecca Kirschner, et al. (Abstract)
E62: Analyzing the choosing wisely patient population: An NCDB study, Noah Rozich, Maharaj Singh, Nicole Zaremba, et al. (Abstract)
Pulmonary open, robotic and thoracoscopic lobectomy (PORTaL) study: An analysis of 5,721 cases, Michael S Kent, Matthew G Hartwig, Eric Vallières, et al. (Article)
Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing, Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al. (Article)
Evaluating pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy and/or chemotherapy using real-world and clinical trial data, Qi Liu, Chenan Zhang, Yue Huang, et al. (Article)
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit, Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen, et al. (Article)
Analysis of local control outcomes and clinical prognostic factors in localized pelvic Ewing sarcoma patients treated with radiation therapy: A Report from the Children's Oncology Group, Safia K. Ahmed, Brent G. Witten, William S. Harmsen, et al. (Article)
The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world, Sakti Chakrabarti, Marie Parish, Carrie Peterson, et al. (Abstract)
Works from 2022
COVID-19 vaccine effectiveness in patients with hematologic malignancy, Dimpy P. Shah, Pankil K. Shah, and Michael A. Thompson (Editorial)
Blood and marrow transplantation (BMT) within four weeks of Sars-Cov-2 infection is associated with increased risk of mortality: A national COVID cohort collaborative study, Meera Mohan, Nathaniel Verhagen, Aditya Shreenivas, et al. (Abstract)
Analysis of local control outcomes and clinical prognostic factors in localized pelvic Ewing Sarcoma patients treated with radiation therapy: A report from the Children's Oncology Group, S K. Ahmed, Brent Witten, W S. Harmsen, et al. (Abstract)
Impact of donation aftercirculatory death allografts on outcomes after liver transplant for hepatitis C: A single-center experience and review of the literature, Shiva Kumar, Rachel Pedersen, and Ajay Sahajpal (Article)
A statewide approach to reducing re-excision rates for women with breast conserving surgery, Jessica R. Schumacher, Elise H. Lawson, Amanda L. Kong, et al. (Article)
Quantifying the value of the molecular tumor board: Discordance recommendation rate and drug cost avoidance, Mary K. Walters, Andrew T. Ackerman, James L. Weese, et al. (Article)
Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis, Sushmita Gordhandas, Brooke A. Schlappe, Qin Zhou, et al. (Article)
Online medical misinformation in cancer: Distinguishing fact from fiction, Eleonora Teplinsky, Sara Beltrán Ponce, Emily K. Drake, et al. (Article)
Social media and professional development for oncology professionals, Anusha Chidharla, Audun Utengen, Deanna J. Attai, et al. (Article)
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies, Michael A. Thompson, Sigrun Hallmeyer, Veronica E. Fitzpatrick, Yunqi Liao, Michael P. Mullane, Stephen C. Medlin, Kenneth Copeland, and James L. Weese (Original Research)
Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma, Benjamin A. Derman, Andrzej J. Jakubowiak, and Michael A. Thompson (Letter)
Pre-operative embolization, surgical resection, and follow-up evaluation of a giant intercostal schwannoma, Mason A. Brown, JiaHao Hu, William Tisol, et al. (Article)
General surgery training in the USA, UK, and India: A scrutiny of strength and challenges, Gaurav Jain, Chandrakanth Are, Vikesh Agrawal, et al. (Article)
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: A cohort study from the COVID-19 and Cancer Consortium, Arielle Elkrief, Cassandra Hennessy, Nicole M. Kuderer, et al. (Article)
Racial disparities in COVID-19 outcomes among black and white patients with cancer, Julie Fu, Sonya A. Reid, Michael Thompson, et al. (Article)
BRE12-158: A postneoadjuvant, randomized phase II trial of personalized therapy versus treatment of physician's choice for patients with residual triple-negative breast cancer, Bryan P. Schneider, Guanglong Jiang, Tarah J. Ballinger, et al. (Article)
HealthTree Cure Hub: A patient-derived, patient-driven clinical cancer information platform used to overcome hurdles and accelerate research in multiple myeloma, Nathan W. Sweeney, Jennifer M. Ahlstrom, Faith E. Davies, et al. (Article)
Pilot study to reliably measure the tissue concentration of mitomycin c after hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal malignancies, Isaac Kriley, Noah Rozich, Geoffrey Bellini, et al. (Abstract)
Assessment of regional variability in COVID-19 outcomes among patients with cancer in the United States, Jessica E. Hawley, Mitrianna Streckfuss, Michael A. Thompson, et al. (Article)
Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system, Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al. (Abstract)
Neoadjuvant chemotherapy is associated with improved outcomes in patients with stage 1A and 1B pancreatic cancer undergoing surgery: An NCDB study, Noah Rozich, Maharaj Singh, Isaac Kriley, et al. (Abstract)
Works from 2021
Abstract p159: molecular tumor board impact at two large health systems, Jennifer Godden, Michael A. Thompson, James Weese, et al. (Abstract)
Treatment patterns and survival outcomes of patients with acute myeloid leukemia who achieved remission in the connect ® myeloid disease registry, Michael A. Thompson (Abstract)
Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (aml) in community health systems in the united states: a real-world data analysis, Zartash Gul and Michael A. Thompson (Abstract)
Refining a Postpandemic Approach to Cancer Screening, Michael A. Thompson (From the Editor)
P10.03 Pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis of key prognostic factors, S Gadgeel, Mohamed Hendawi, James Weese, et al. (Abstract)
P10.04 Immunotherapy-treated non-small cell lung cancer patients with sensitizing gene alterations: A real world survival analysis, L Khaddour, Eyob Tadesse, Michael A. Thompson, et al. (Abstract)
Oncofetal chondroitin sulfate is a highly expressed therapeutic target in non-small cell lung cancer, Htoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, et al. (Article)
COVID-19 and cancer: A review of the registry-based pandemic response, Aakash Desai, Turab J Mohammed, Narjust Duma, et al. (Article)
Dosimetric benefits of omitting primary tumor beds in postoperative radiotherapy after transoral robotic surgery using the auto-planning technique, Taoran Cui, Matthew C. Ward, Jeffrey A. Kittel, et al. (Article)
MPN-390: Study design and objectives for a new cohort of patients with myelofibrosis (MF) enrolled in the ongoing Connect® Myeloid Disease Registry, John Mascarenhas, Michael Savona, Michael A. Thompson, et al. (Abstract)
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US, Faith Davies, Robert Rifkin, Caitlin Costello, et al. (Article)
Real-world performance of a comprehensive genomic profiling test optimized for small tumor samples, Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga, et al. (Article)
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19, Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al. (Article)
Abstract 2618: Staged analysis of standard of care tumor molecular testing among patients with metastatic colorectal cancer in the community health system setting, Michael A. Thompson, Anthony Ruggeri, Jennifer Godden, et al. (Abstract)
Impact of the COVID-19 pandemic on oncologist burnout, emotional well-being, and moral distress: Considerations for the cancer organization's response for readiness, mitigation, and resilience, Fay J Hlubocky, Banu E Symington, Daniel C McFarland, et al. (Article)
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma, Roman Hájek, Jiří Minařík, Jan Straub, et al. (Article)
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19, Michael A. Thompson, Jeffrey P Henderson, Pankil K Shah, et al. (Article)
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, P Grivas, A R Khaki, T M Wise-Draper, et al. (Article)
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes, Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al. (Article)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Prognostic Implications of Vitamin D in Patients With a Hematologic Malignancy at a Large Health System in Wisconsin, Daniel Mundt, Marianne Klumph, Kayla Heslin, and Michael A. Thompson (Abstract)
Use of convalescent plasma in COVID-19 patients with immunosuppression, Jonathon W Senefeld, Stephen A Klassen, Shane K Ford, et al. (Article)
Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems, Clara Hwang, Monika A Izano, Michael A. Thompson, et al. (Article)
ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation, Shaji Kumar, Zihan Wei, Michael A. Thompson, et al. (Abstract)
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types, Kristen Hanson, Michael P. Mullane MD, Deborah Wham, et al. (Abstract)
Modernizing clinical trial eligibility criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group, Alexander I Spira, Mark D Stewart, Suzanne Jones, et al. (Article)
Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center, Mohamed Hendawi, Luke Peterson, Eyob Tadesse, et al. (Abstract)
People with cancer are likely to accept the covid-19 vaccine, but politics tracks with attitudes: An inspire and cosmo survey, Don Dizon, Kathleen Hoffman, Michael A. Thompson, et al. (Abstract)
Care without a compass: including patients with cancer in COVID-19 studies, Christopher R Friese, Toni K Choueiri, Narjust Duma, et al. (Article)
Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study, Ali Raza Khaki, Dimpy Shah, Michael A. Thompson, et al. (Abstract)
Recommendations to streamline and standardize clinical trial site feasibility assessments: An ASCO research statement, Dax Kurbegov, Patricia Hurley, David M Waterhouse, et al. (Article)
Works from 2020
A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance, M Abidi, DM Aboulafia, Michael A. Thompson, et al. (Article)
Incidence of and risk factors for venous thromboembolism among hospitalized patients with cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry, Ang Li, Nicole M Kuderer, Jeremy L. Warner, et al. (Abstract)
Post-remission treatment (Tx) patterns for patients (Pts) with newly diagnosed (ND) acute myeloid leukemia (AML) in the Connect® MDS/AML Disease Registry, Gail J. Roboz, Michael A. Thompson, and et al (Abstract)
Real world observational study using Clonoseq® next generation sequencing in hematologic malignancies: The 'Watch' Registry, Krish Patel, Neil Bailey, Michael A. Thompson, et al. (Abstract)
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study, Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al. (Article)
Waging war on war metaphors in cancer and COVID-19, Jonathan M Marron, Don S Dizon, Banu Symington, et al. (Article)